CClinicalTrials.gg
CompletedNCT02873078Updated Sep 16, 2020

Internet-Delivered CBT for Children With Functional Abdominal Pain Disorders

An interventional study of Internet-delivered Cognitive behavior therapy in Functional Abdominal Pain Disorders, sponsored by Karolinska Institutet. Completed at 1 site in Sweden. Open to participants aged 8 Years to 12 Years. Per ClinicalTrials.gov, last updated 2020-09-16.

Sponsored by Karolinska Institutet · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
91
Allocation
Randomized
Ages
8 Years to 12 Years
Sex
All
01

Study summary

This randomized controlled study aims to evaluate the efficacy of exposure-based Internet-delivered cognitive behavior therapy for children 8-12 years with Functional Abdominal Pain Disorders. The children participate along with their parents, who will also receive specific modules with information on how to support their children in the treatment. Predictors and mediators for treatment effects will be studied as well as the cost effectiveness of the intervention.

02

Conditions studied

  • Functional Abdominal Pain Disorders
03

In context

Abdominal Pain

338 studies on the registry are indexed under Abdominal Pain; 55 are open to participants now.

This study's enrollment of 91 is above the median of 72 across 250 interventional studies indexed under Abdominal Pain.

Browse Abdominal Pain studies →

Lead sponsor

Karolinska Institutet is the lead sponsor of 1,113 studies on the registry; 267 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Children 8-12 years with either irritable bowel syndrome, functional dyspepsia or functional abdominal pain - not otherwise specified diagnosed according to Rome-III or Rome-IV criteria.
  • Psychopharmacological medication stable for at least a month if medicating.
  • Child and at least one parent speaking and writing swedish.
  • Access to computer with Internet connection.

Exclusion criteria

Exclusion Criteria:

  • Severe somatic disorder and/or if the child fulfills criteria of other disorder that better explains the abdominal symptoms.
  • Severe psychiatric or social problems that needs other care.
  • Ongoing psychological treatment.
  • School absenteeism more than 40 %.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
91 participants (actual)

Study arms

  • Experimental
    Internet-delivered CBT

    Children and parents will receive 10 weekly modules of cognitive behavior therapy (CBT). Parents will also receive 10 weekly modules. Main components in the children's modules are exposure for abdominal symptoms, feared stimuli and situations in which the children are afraid of having symptoms. The parental receive information on how they can support their children in the treatment and how to reinforce health y behaviors and decrease attention to pain behaviors. Therapist support is provided through written messages within the secure platform.

    Behavioral: Internet-delivered Cognitive behavior therapy

  • No intervention
    Waiting list

    This is a wait-list control where the children and parents are allowed to carry on with any contacts within the health-care system, exempt for psychological treatments.

Interventions

  • BehavioralInternet-delivered Cognitive behavior therapy

    The treatment is delivered via an online platform and is based on interventions for adults, adolescents and children tested in previous trials. Therapists are CBT-psychologists och students in clinical psychology under supervision.

06

What researchers measure

Primary outcomes

  1. PedsQL Gastro

    Change in gastrointestinal symptoms measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

    Time frame: Baseline to 10 weeks, baseline to 9 months, baseline to 15 months

Secondary outcomes

  1. Faces Pain Rating Scale

    Change in pain intensity measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

    Time frame: Baseline to 10 weeks, baseline to 9 months, baseline to 15 months

  2. Faces Pain Rating Scale

    Change in pain intensity measured with a self-rating scale weekly during treatment for mediation analyses.

    Time frame: Weekly during treatment (treatment week 1-9).

  3. Faces Pain Rating Scale rated by parents

    Change in child's pain intensity measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

    Time frame: Baseline to 10 weeks, baseline to 9 months, baseline to 15 months

  4. Faces Pain Rating Scale rated by parents

    Change in pain intensity measured with a self-rating scale weekly during treatment for mediation analyses.

    Time frame: Weekly during treatment (treatment week 1-9).

  5. PedsQL Gastro rated by parents

    Change in child gastrointestinal symptoms measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

    Time frame: Baseline to 10 weeks, baseline to 9 months, baseline to 15 months

  6. PedsQL Gastro rated by parents

    Change in child gastrointestinal symptoms measured with a self-rating scale weekly during treatment for mediation.

    Time frame: Weekly during treatment (treatment week 1-9).

  7. Pediatric quality of life inventory (PedsQL QOL)

    Change in quality of life measured measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

    Time frame: Baseline to 10 weeks, baseline to 9 months, baseline to 15 months

  8. Pediatric quality of life inventory (PedsQL QOL) rated by parents

    Change in child quality of life measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

    Time frame: Baseline to 10 weeks, baseline to 9 months, baseline to 15 months

  9. Painfree days

    Change in pain free days measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

    Time frame: Baseline to 10 weeks, baseline to 9 months, baseline to 15 months

  10. Painfree days

    Change in pain free days measured with a self-rating scale weekly during treatment for mediation analyses.

    Time frame: Weekly during treatment (treatment week 1-9)

  11. Painfree days rated by parents

    Change in child's pain free days measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

    Time frame: Baseline to 10 weeks, baseline to 9 months, baseline to 15 months

  12. Painfree days rated by parents

    Change in child's pain free days measured with a self-rating scale weekly during treatment for mediation analyses.

    Time frame: Weekly during treatment (treatment week 1-9)

  13. IBS-Behavioral responses questionnaire (IBS-BRQ)

    Change in childs behavioral responses to abdominal symptoms measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

    Time frame: Baseline to 10 weeks, baseline to 9 months, baseline to 15 months

  14. IBS-Behavioral responses questionnaire (IBS-BRQ)

    Change in child's behavioral responses to abdominal symptoms measured with a self-rating scale weekly during treatment for mediation analyses.

    Time frame: Weekly during treatment (treatment week 1-9)

  15. IBS-Behavioral responses questionnaire (IBS-BRQ) parental version

    Change in child's behavioral responses to abdominal symptoms measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

    Time frame: Baseline to 10 weeks, baseline to 9 months, baseline to 15 months

  16. IBS-Behavioral responses questionnaire (IBS-BRQ) parental version

    Change in child's behavioral responses to abdominal symptoms measured with a self-rating scale weekly during treatment for mediation analyses.

    Time frame: Weekly during treatment (treatment week 1-9)

  17. Spence Children Anxiety Scale - short version (SCAS-S)

    Change in child's anxiety symptoms measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

    Time frame: Baseline to 10 weeks, baseline to 9 months, baseline to 15 months

  18. Spence Children Anxiety Scale - short version (SCAS-S) rated by parents

    Change in child's anxiety symptoms measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

    Time frame: Baseline to 10 weeks, baseline to 9 months, baseline to 15 months

  19. Child Depression Inventory - short version (CDI-S)

    Change in child's depressive symptoms measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

    Time frame: Baseline to 10 weeks, baseline to 9 months, baseline to 15 months

  20. Visceral Sensitivity Index

    Change in visceral sensitivity measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

    Time frame: Baseline to 10 weeks, baseline to 9 months, baseline to 15 months

  21. Visceral Sensitivity Index

    Change in visceral sensitivity measured with a self-rating scale weekly during treatment for mediation analyses.

    Time frame: Weekly during treatment (treatment week 1-9)

  22. Client Satisfactory Questionnaire (CSQ)

    Client satisfaction rated measured with a self-rating scale

    Time frame: At week 10

  23. Client Satisfactory Questionnaire (CSQ) rated by parents

    Client satisfaction rated measured with a self-rating scale

    Time frame: At week 10

  24. Subjective Assessment Questionnaire (SAQ)

    Subjective change in symptoms measured with a self-rating scale

    Time frame: At week 10

  25. Subjective Assessment Questionnaire (SAQ) rated by parents

    Subjective change in the child's symptoms measured with a self-rating scale by the parents.

    Time frame: At week 10

  26. Rome-IV questionnaire

    Change in diagnostic status of functional abdominal pain disorder measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

    Time frame: Baseline to 10 weeks, baseline to 9 months, baseline to 15 months

  27. Kidscreen

    Change in quality of life for use in economic evaluation measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

    Time frame: Baseline to 10 weeks, baseline to 9 months, baseline to 15 months

  28. School absenteeism rated by parents

    Change in child's school absenteeism measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

    Time frame: Baseline to 10 weeks, baseline to 9 months, baseline to 15 months

  29. School absenteeism rated by parents

    Change in child's school absenteeism measured with a self-rating scale weekly during treatment for mediation analyses.

    Time frame: Weekly during treatment (treatment week 1-9)

  30. Pain Catastrophizing Scale, parental version (PCS-P)

    Change in parental catastrophizing of the child's symptoms measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

    Time frame: Baseline to 10 weeks, baseline to 9 months, baseline to 15 months

  31. Pain Catastrophizing Scale, parental version (PCS-P)

    Change in parental catastrophizing of the child's symptoms measured with a self-rating scale weekly during treatment for mediation analyses.

    Time frame: Weekly during treatment (treatment week 1-9)

  32. Children´s Somatization Inventory (CSI 24) rated by parents

    Change in child's somatization symptoms measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

    Time frame: Baseline to 10 weeks, baseline to 9 months, baseline to 15 months

  33. Adverse events (AE)

    Adverse events during treatment measured with a self-rating scale by the parents.

    Time frame: At week 10

  34. Working Alliance Inventory (WAI) short version

    Working alliance in first three weeks of treatment measured with a self-rating scale by the parents.

    Time frame: At week 4

  35. The treatment credibility scale rated by parents.

    Treatment credibility measured with a self-rating scale by the parents.

    Time frame: At week 2

  36. Trimbos and Institute of Technology Cost Questionnaire for Psychiatry (TIC-P) rated by parents

    Costs associated with the disorder measured with a self-rating scale by the parents.

    Time frame: Baseline, at weeks 3, 7, 10 and at 9 months

  37. General health questionnaire (GHQ-12) rated by parents

    Change in general health measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

    Time frame: Baseline to 10 weeks, baseline to 9 months, baseline to 15 months

  38. Generalised anxiety disorder assessment (GAD 7) rated by parents

    Change in parental anxiety symptoms measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

    Time frame: Baseline to 10 weeks, baseline to 9 months, baseline to 15 months

  39. Adult responses to children's symptoms (ARCS) rated by parents

    Change in parental responses to child's symptoms measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

    Time frame: Baseline to 10 weeks, baseline to 9 months, baseline to 15 months

  40. Adult responses to children's symptoms (ARCS) rated by parents

    Change in parental responses to child's symptoms measured with a self-rating scale weekly during treatment for mediation analyses.

    Time frame: Weekly during treatment (treatment week 1-9)

  41. PedsQL Gastro

    Change in gastrointestinal symptoms measured with a self-rating scale weekly during treatment for mediation analyses.

    Time frame: Weekly during treatment (treatment week 1-9).

07

Study locations

1 site
  • Child and Adolescent Psychiatry in Stockholm
    Stockholm, 11330, Sweden
08

References and documents

Publications

  • Lalouni M, Ljotsson B, Bonnert M, Ssegonja R, Benninga M, Bjureberg J, Hogstrom J, Sahlin H, Simren M, Feldman I, Hedman-Lagerlof E, Serlachius E, Olen O. Clinical and Cost Effectiveness of Online Cognitive Behavioral Therapy in Children With Functional Abdominal Pain Disorders. Clin Gastroenterol Hepatol. 2019 Oct;17(11):2236-2244.e11. doi: 10.1016/j.cgh.2018.11.043. Epub 2018 Nov 28. PubMed 30502501 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 16, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02873078
Lead sponsor
Karolinska Institutet
Responsible party
Ola Olen (MD PhD, Karolinska Institutet) — Principal investigator
First posted
Aug 19, 2016
Start date
Aug 2016
Primary completion
Jan 2018
Completion
Jan 2018
Last update
Sep 16, 2020

Study contacts

Ola Olén, MD PhD
principal investigator · Karolinska Institutet

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion